BCDIN3D Human Pre-designed siRNA Set A contains three designed siRNAs for BCDIN3D gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

BCH-HSP-C01 is a lead compound that restores AP-4-dependent protein trafficking in neuronal models of adapter protein complex 4 (AP-4)-associated hereditary spastic paraplegia. BCH-HSP-C01 can be used for the research of autophagy-associated diseases[1].

BCHE Human Pre-designed siRNA Set A contains three designed siRNAs for BCHE gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Bche Mouse Pre-designed siRNA Set A contains three designed siRNAs for Bche gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

Bche Rat Pre-designed siRNA Set A contains three designed siRNAs for Bche gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

BChE-IN-28 (compound 6J) is a selective butyrylcholinesterase (BChE) inhibitor with an IC50 of 8 nM and a Ki of 12.16 nM. BChE-IN-28 shows the lower inhibition against AChE, MAO-A and MAO-B[1].

BChE-IN-29 (Compound 27a) is a BChE inhibitor (IC50: 0.078 μM and 0.74 μM for BChE and AChE respectively). BChE-IN-29 has anti-inflammatory activity and can be used for research of AD[1].

BChE-IN-30 (compound (R)-37a) is a BChE inhibitor (IC50: 5 nM) with anti-inflammatory activity and low toxicity. BChE-IN-30 can improve cognitive deficits induced by scopolamine and Aβ1-42 peptide and can be used in the study of late-stage AD[1].

BChE-IN-31 (Compound 14d) is a selective BChE inhibitor with an IC50 of 65 nM. BChE-IN-31 inhibits the self-induced aggregation of neurotoxic amyloid-β (Aβ) peptide[1].

ChE-IN-32 (compound 5d) is a potent and selective hBChE inhibitor with an IC50 value of 0.109 µM. BChE-IN-32 shows cytotoxicity. BChE-IN-32 has the potential for the research of Alzheimer’s disease[1].

BCIP (dipotassium) is a multifunctional dye. Dyes are important tools in biological experiments. They can help researchers observe and analyze cell structures, track biomolecules, evaluate cell functions, distinguish cell types, detect biomolecules, study tissue pathology and monitor microorganisms. Their applications range from basic scientific research to clinical A wide range of diagnostics. Dyes are also […]

BCKDHA Human Pre-designed siRNA Set A contains three designed siRNAs for BCKDHA gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

BCKDHB Human Pre-designed siRNA Set A contains three designed siRNAs for BCKDHB gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

BCKDK Human Pre-designed siRNA Set A contains three designed siRNAs for BCKDK gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Bcl-2-IN-18 (Compound 23) is a breast cancer Bcl-2 inhibitor with a IC50 value of 4.7 μM for MCF-7. Bcl-2-IN-18 has antitumor activity[1].

Bcl-2-IN-19 (compound 27) is a potent Bcl-2 inhibitor for targeting breast cancer[1].

BCL-xL/BCL-2 ligand 1 (compound 72-1) is a BCL-xL and BCL-2 protein ligand. BCL-xL/BCL-2 ligand 1 can be connected to the E3 ligase by a linker to form PROTACs (HY-161410)[1][2].

BCL10 Human Pre-designed siRNA Set A contains three designed siRNAs for BCL10 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

BCL11A Human Pre-designed siRNA Set A contains three designed siRNAs for BCL11A gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

BCL11B Human Pre-designed siRNA Set A contains three designed siRNAs for BCL11B gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

BCL2 Human Pre-designed siRNA Set A contains three designed siRNAs for BCL2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Bcl2 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Bcl2 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

BCL2 Rat Pre-designed siRNA Set A contains three designed siRNAs for BCL2 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

BCL2A1 Human Pre-designed siRNA Set A contains three designed siRNAs for BCL2A1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Bcl2a1 Rat Pre-designed siRNA Set A contains three designed siRNAs for Bcl2a1 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

Bcl2a1a Mouse Pre-designed siRNA Set A contains three designed siRNAs for Bcl2a1a gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

BCL2L1 Human Pre-designed siRNA Set A contains three designed siRNAs for BCL2L1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Bcl2l1 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Bcl2l1 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

Bcl2l1 Rat Pre-designed siRNA Set A contains three designed siRNAs for Bcl2l1 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

BCL2L10 Human Pre-designed siRNA Set A contains three designed siRNAs for BCL2L10 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Bcl2l10 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Bcl2l10 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

Bcl2l10 Rat Pre-designed siRNA Set A contains three designed siRNAs for Bcl2l10 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

BCL2L11 Human Pre-designed siRNA Set A contains three designed siRNAs for BCL2L11 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Bcl2l11 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Bcl2l11 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

Bcl2l11 Rat Pre-designed siRNA Set A contains three designed siRNAs for Bcl2l11 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

BCL2L12 Human Pre-designed siRNA Set A contains three designed siRNAs for BCL2L12 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

BCL2L13 Human Pre-designed siRNA Set A contains three designed siRNAs for BCL2L13 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

BCL2L14 Human Pre-designed siRNA Set A contains three designed siRNAs for BCL2L14 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

BCL2L15 Human Pre-designed siRNA Set A contains three designed siRNAs for BCL2L15 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

BCL2L2 Human Pre-designed siRNA Set A contains three designed siRNAs for BCL2L2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Bcl2l2 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Bcl2l2 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

Bcl2l2 Rat Pre-designed siRNA Set A contains three designed siRNAs for Bcl2l2 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

BCL3 Human Pre-designed siRNA Set A contains three designed siRNAs for BCL3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

BCL6 Human Pre-designed siRNA Set A contains three designed siRNAs for BCL6 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.